How has been the historical performance of Anuh Pharma?

Answer:The historical performance of Anuh Pharma shows a steady growth in net sales and profit over the years, with some fluctuations in operating and profit margins. Breakdown: Anuh Pharma's net sales have increased from 306.96 Cr in Mar'20 to 661.51 Cr in Mar'25, reflecting a consistent upward trend. Total operating income followed a similar trajectory, rising from 306.96 Cr in Mar'20 to 661.51 Cr in Mar'25. However, the raw material costs peaked at 489.73 Cr in Mar'24 before declining to 463.28 Cr in Mar'25, while employee costs have gradually increased from 10.14 Cr in Mar'19 to 23.04 Cr in Mar'25. Operating profit (PBDIT) saw a peak of 87.24 Cr in Mar'24 but fell to 70.36 Cr in Mar'25, indicating some pressure on profitability. Profit before tax also experienced fluctuations, reaching 61.01 Cr in Mar'25 after peaking at 78.31 Cr in Mar'24. Profit after tax followed suit, decreasing to 47.35 Cr in Mar'25 from 60.06 Cr in Mar'24. The company's total assets increased from 326.37 Cr in Mar'20 to 504.55 Cr in Mar'25, while total liabilities rose from 326.37 Cr to 504.55 Cr in the same period. Cash flow from operating activities improved significantly, reaching 37.00 Cr in Mar'25 compared to 12.00 Cr in Mar'24, contributing to a net cash inflow of 12.00 Cr in Mar'25. Overall, Anuh Pharma has demonstrated growth in sales and assets, although profitability metrics have shown some volatility in recent years.